Orphazyme A/S (CPH: ORPHA)
Denmark
· Delayed Price · Currency is DKK
1,248.40
+49.00 (4.09%)
Oct 1, 2024, 4:47 PM CET
Orphazyme Employees
Orphazyme had 1 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
1
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-11.42M DKK
Market Cap
49.64M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Novo Nordisk A/S | 64,319 |
Coloplast A/S | 15,692 |
Genmab A/S | 2,204 |
Zealand Pharma A/S | 253 |
Demant A/S | 21,623 |
H. Lundbeck A/S | 5,681 |
H. Lundbeck A/S | 5,681 |
ALK-Abelló A/S | 2,824 |
Orphazyme News
- 1 year ago - Orphazyme Announces Publication of 2022 Financial Results and Annual Report - GlobeNewsWire
- 2 years ago - Orphazyme reports financial results in Interim Report First Half 2022 - GlobeNewsWire
- 2 years ago - Orphazyme Announces Publication of 2021 Financial Results and Annual Report - GlobeNewsWire
- 2 years ago - Orphazyme completes sale of substantially all of its assets and business activities to KemPharm - GlobeNewsWire
- 2 years ago - Orphazyme A/S under In-Court-Restructuring to sell substantially all of its assets and business activities to KemPharm, Inc. - GlobeNewsWire
- 2 years ago - Orphazyme announces update on in-court restructuring proceedings - GlobeNewsWire
- 2 years ago - Orphazyme Withdraws European Application For Arimoclomol, Initiates Delisting Of Its ADSs - Benzinga
- 2 years ago - Orphazyme announces withdrawal of European Marketing Authorisation Application for arimoclomol for the treatment of Niemann-Pick disease type C - GlobeNewsWire